Allergy Shot Treatment: Program Arc from Build-Up to Remission
Allergy shot treatment is subcutaneous immunotherapy (SCIT) understood as a multi-year program — from IgE-confirmed diagnosis through 3-5 years of injections to disease-modifying remission. Cochrane meta-analysis (51 RCTs / 2,871 patients) found symptom SMD -0.73. Durham 1999 NEJM documented remission persisting years after stopping. The real-world ceiling: only 43.9% of initiators reach maintenance (Tkacz 2021).
6 peer-reviewed sources
Allergy shot treatment is the full SCIT program — IgE testing, extract prescription, 24-28 weekly build-up injections, then 3-5 years of maintenance every 2-4 weeks — producing disease-modifying remission that outlasts the treatment course.
The essentials
Allergy shot treatment pairs the lay term 'allergy shot' with the medical-treatment frame, signaling a reader who has moved past 'what is it' and wants the treatment-as-program answer. The AAAAI/ACAAI/JCAAI Practice Parameter Third Update (Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1-S55, DOI 10.1016/j.jaci.2010.09.034) defines the standard treatment arc as five stages:
1. Diagnostic confirmation. IgE sensitization confirmed by skin prick test (wheal ≥3 mm above negative control) or specific IgE blood test (≥0.35 kUA/L), with symptomatic correlation. Only confirmed IgE-mediated sensitizations are indicated for SCIT.
2. Extract prescription. The allergist custom-composes a vial from FDA-licensed allergen extract(s) specific to the patient's sensitization profile. Single-allergen or multi-allergen vials depending on sensitization breadth (Cox 2011 Summary Statement 72).
3. Build-up phase. Conventional: 24-28 weekly injections over 3-6 months. Cluster (Tabar AI et al., JACI 2005;116:109-118): maintenance in 4-8 weeks with 2-4 injections per visit. Rush: 1-3 days. Mandatory 30-minute observation after each injection.
4. Maintenance phase. Every 2-4 weeks for 3-5 years, same 30-minute observation. Adherence data: only 43.9% of 103,207 MarketScan initiators reached maintenance (Tkacz JP et al., Curr Med Res Opin 2021;37(6):957-965, DOI 10.1080/03007995.2021.1903848); 23.9% never returned after the first injection.
5. Outcome and end-of-treatment. Cochrane symptom SMD -0.73 and medication SMD -0.57 (Calderón MA et al., 2007, DOI 10.1002/14651858.CD001936.pub2). Disease-modifying durability: Durham SR et al. (N Engl J Med 1999;341:468-475) demonstrated remission persisting years after a 3-4 year course ended. Children: asthma prevention OR 4.6 at 10-year follow-up (Jacobsen L et al., Allergy 2007 PAT study).
The key distinction from symptomatic treatments: antihistamines and intranasal corticosteroids achieve comparable short-term symptom control but provide no benefit after stopping. Allergy shot treatment changes the immune program.
Before any multi-year allergy shot treatment is started, Curex's at-home IgE blood test with allergist review confirms which allergens to target and whether SCIT or SLIT is clinically appropriate.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The allergy shot treatment timeline is the program arc that makes SCIT disease-modifying rather than just symptomatic.
24-28 weekly injections escalating from 0.05 mL to 0.5 mL of the maintenance concentrate. Cluster (Tabar 2005): 4-8 weeks with 2-4 injections per visit. Rush (Bernstein 2008): 1-3 days with pre-medication. Mandatory 30-minute observation after every injection.
Maintenance injections continue every 2-4 weeks for 3-5 years. Disease benefits accumulate and peak at 1-2 years of maintenance. Gaps of 3-4+ months require restarting from an earlier build-up dilution. The real-world completion rate is 43.9% (Tkacz 2021).
Durham SR et al. (N Engl J Med 1999;341:468-475): sustained remission after a completed 3-4 year course. Jacobsen L et al. (Allergy 2007, PAT 10-year follow-up): asthma prevention OR 4.6 in children who completed treatment. Patients experiencing symptom return years later may discuss retreatment with their allergist.
Efficacy by allergen — what the data shows
The disease-modifying evidence for allergy shot treatment is the key clinical argument for completing the full course. Cochrane meta-analysis (Calderón 2007) found SMD -0.73; real-world benefits are contingent on reaching and completing maintenance (Tkacz 2021 completion rate: 43.9%).
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Allergy shot treatment vs SLIT drops is the core decision for patients who want disease-modifying immunotherapy.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Allergy Shots (Curex SCIT) | |||||
SLIT Drops (Sublingual) | |||||
Pharmacotherapy (Antihistamines + Nasal Steroids) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients who want the full immunotherapy program without years of clinic trips, Curex delivers the same SCIT injection course as one weekly shot you give yourself at home for $129/month — a personalized serum sterile-compounded to USP <797>, prescribed by a board-certified allergist, with your first dose and every dose change supervised live over Zoom across the same 3-to-5-year arc.
See if at-home shots are right for youFrequently asked questions
How long is allergy shot treatment?
Allergy shot treatment (SCIT) lasts 3-5 years total: build-up phase of approximately 24-28 weekly injections over 3-6 months, followed by maintenance injections every 2-4 weeks for 3-5 years. Total clinic visits: approximately 60-80+ over the course. After completing the full treatment, disease-modifying remission persists for an average of 3-12 years without further injections per Durham SR et al. (N Engl J Med 1999;341:468-475). The 'treatment' doesn't end at the last injection — the immunological reprogramming continues.
Does allergy shot treatment work?
Yes — for patients who complete the course. Cochrane meta-analysis (Calderón MA et al., 2007, 51 RCTs / 2,871 patients, DOI 10.1002/14651858.CD001936.pub2) found symptom SMD -0.73 (95% CI -0.97 to -0.50) and medication SMD -0.57. Disease-modifying remission persists years after stopping (Durham 1999 NEJM). For specific allergens: ragweed 85% reduction (Creticos 1996 NEJM); grass pollen ~80%; cat dander 70-72% (Varney 1997). The real-world qualification: only 43.9% of initiators reach maintenance (Tkacz 2021), so completion is the primary determinant of outcome.
What is the success rate of allergy shot treatment?
Cochrane meta-analysis places the symptom SMD at -0.73 across 51 RCTs — a clinically meaningful reduction corresponding roughly to a one-third improvement in symptoms vs placebo. Approximately 50-85% of patients who complete the full course achieve clinically meaningful improvement per AAAAI summary statistics. The key qualifier is completion: of 103,207 MarketScan patients initiating SCIT, only 43.9% reached maintenance (Tkacz JP et al., Curr Med Res Opin 2021, DOI 10.1080/03007995.2021.1903848). Non-responders after 1 year may warrant reassessment of their sensitization profile, compliance, or whether the allergens being treated are the actual drivers of their symptoms.
Can allergy shot treatment be done faster?
Yes — cluster and rush build-up protocols compress the build-up phase. Cluster immunotherapy (2-4 injections per visit at 30-minute intervals) reaches maintenance in 4-8 weeks versus 3-6 months for conventional weekly build-up (Tabar AI et al., J Allergy Clin Immunol 2005;116:109-118). Rush immunotherapy (multiple injections over 1-3 days) is available at specialized centers with pre-medication. Both accelerated protocols carry higher per-injection systemic-reaction risk: Johns Hopkins analysis found approximately 3-fold higher systemic-reaction risk for cluster vs conventional; rush protocols historically showed systemic-reaction rates up to 36%. Maintenance duration (3-5 years) is the same regardless of the build-up speed.
Does allergy shot treatment prevent asthma?
Yes — allergen immunotherapy has demonstrated asthma-prevention benefit beyond treating rhinitis symptoms. Jacobsen L et al. (Allergy 2007;62:943-948, PAT 10-year follow-up) found SCIT-treated children had an adjusted OR of 4.6 (95% CI 1.5-13.7) for asthma prevention versus controls who received pharmacotherapy only. Möller C et al. (J Allergy Clin Immunol 2002) confirmed the preventive effect with sublingual immunotherapy. No pharmacotherapy (antihistamines, intranasal corticosteroids) has demonstrated asthma prevention from allergic rhinitis. This is one of the strongest arguments for starting allergy shot treatment earlier rather than later in allergic patients.
What happens after completing allergy shot treatment?
After completing a 3-5 year SCIT course, disease-modifying remission persists for an average of 3-12 years without further injections. Durham SR et al. (N Engl J Med 1999;341:468-475) demonstrated sustained clinical remission after a 3-4 year grass-pollen SCIT course ended. The mechanism of persistence involves long-lived plasma cells in bone marrow niches that continue producing allergen-specific IgG4 blocking antibodies years after the last injection. Some patients experience symptom return 5-10 years after completing treatment and may discuss retreatment with their allergist. There is no defined 'booster' protocol; the decision to retreat is based on clinical reassessment.
Related Articles
Names of Allergy Shots for Adults | Curex Guide
The clinical name is SCIT. Extracts come from Greer, ALK-Abelló, or Stallergenes Greer. FDA-approved branded tablets: Grastek, Oralair, Ragwitek, Odactra.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Test Shots vs Treatment: CPT Codes | Curex
Allergy test shots (CPT 95004 prick, CPT 95024 intradermal) diagnose sensitization in one visit. Treatment shots (SCIT, CPT 95115/95117) are a 3-5 year immunotherapy course.
Read morePollen Allergy Shot: 3-Way Triage Guide | Curex
Pollen allergy shot triage: depot steroid (discouraged), SLIT tablet, or SCIT. Curex at-home SCIT is category 3: shots weekly at home, $129/month.
Read moreAllergy Injection Site: Anatomy & Technique | Curex
SCIT injections go subcutaneously into the posterolateral upper outer arm, alternating arms each visit. 26-27G needle. Not intramuscular. Not intradermal.
Read moreAllergy Injection: One Visit Explained | Curex
An allergy injection is one step in a 3-to-5-year SCIT course. Learn pre-injection screening, technique, the 30-min observation, and why singular search intent often finds depot steroids instead.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.